Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 7,880 KRW
Change Today -140.00 / -1.75%
Volume 24.5K
064550 On Other Exchanges
As of 8:56 PM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

bioneer corp (064550) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/20/14 - 17,000
52 Week Low
12/18/14 - 6,800
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BIONEER CORP (064550)

Related News

No related news articles were found.

bioneer corp (064550) Related Businessweek News

No Related Businessweek News Found

bioneer corp (064550) Details

Bioneer Corporation, a biotechnology company, develops molecular biology products and technologies in South Korea. The company offers DNA amplification products; synthetic DNA/RNA oligonucleotides; DNA/RNA extraction and purification kits; DNA/RNA synthesis reagents, such as DNA and RNA phosphoramidites, modified phosphoramidites, and controlled pore glasses for oligo synthesis; gene synthesis, mutagenesis, and gene cloning services; AccuGeneBlock service, which includes the synthesis of double strand DNA fragments; qPCR gene expression profiling services; and RNA interference technology products. It also provides a range of enzymes for PCR, reverse transcription, reverse transcriptase PCR, and DNA ligation; protein expression and purification instrumentation and kits; DNA ladders and molecular weight markers; and S. pombe genome-wide deletion mutant library for protein-protein interaction analysis. In addition, the company offers gene synthesis and sequencing services; drug target and toxicity identification services; drug rescue services; buffers and manual sequencing kits; plastic consumables; and instruments for protein synthesis, PCR, sample preparation, centrifuge and vortex mixing, and electrophoresis. Further, it provides molecular diagnostics products, which include platform technologies that integrate reagents and instruments; MDx instruments; and human and veterinary diagnostics kits. Additionally, the company engages in the development of drugs in the areas of cancer, COPD, liver fibrosis, and antivirals through its self-assembled-micelle-inhibitory-RNA prodrug platform technology. Bioneer Corporation was founded in 1992 and is headquartered in Daejeon, South Korea.

Founded in 1992

bioneer corp (064550) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

bioneer corp (064550) Key Developments

Bioneer Corporation, Annual General Meeting, Mar 26, 2015

Bioneer Corporation, Annual General Meeting, Mar 26, 2015., at 10:30 Korea Standard Time. Location: headquarters seminar rooms. Agenda: To consider financial statements and the consolidated financial statements; to approve second article of Articles of incorporation; to consider appointment of directors; to consider election of standing Auditor; to consider grant of stock options; and to consider Director and auditor remuneration.

Bioneer Corporation Presents at HSBC Asia Corporate Day 2014, Nov-17-2014

Bioneer Corporation Presents at HSBC Asia Corporate Day 2014, Nov-17-2014 . Venue: The Mayfair Hotel, Stratton Street, London W1J 8LT, United Kingdom.

Bioneer Corporation Presents at HSBC Asia Investor Forum - Boston, Nov-20-2014

Bioneer Corporation Presents at HSBC Asia Investor Forum - Boston, Nov-20-2014 . Venue: Boston, Massachusetts, United States.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
064550:KS 7,880.00 KRW -140.00

064550 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 064550.
View Industry Companies

Industry Analysis


Industry Average

Valuation 064550 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.3x
Price/Book 3.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIONEER CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at